Bahrain is sparing no efforts to contain cases of swine flu and treat patients who have tested positive for the virus. The Health Ministry is in constant contact with the company that manufactures the H1N1 vaccine to fast-track the delivery of
Johnson & Johnson has begun a clinical trial of a two-shot Ebola vaccine in Sierra Leone, underlining its determination to push ahead with development, even as the epidemic fades out West Africa.
The new st
An estimated 500,000 newborn lives have been saved and 100 million women and their newborns protected from the deadly disease, maternal and newborn tetanus, owing to a 10-year long partnership between Pampers and Unicef that helped achieve thi
A vaccine crucial for immunisation against tuberculosis (TB) is currently in short supply in Bahrain, a leading doctor has revealed. Al Hilal Hospital paediatrician Dr Akhtar Amin said that several patients had come back to him after being una
The world is for the first time on the verge of being able to protect humans against Ebola, the World Health Organization (WHO) said on Friday, as data from a trial in Guinea showed a vaccine was 100 per cent effective.
The world's first malaria vaccine got a green light on Friday from European drugs regulators who recommended it should be licensed for use in babies in Africa at risk of the mosquito-borne disease.
The shot, called RTS,S or Mo
The use of oral vaccines is proving to be an effective tool to control outbreaks of cholera, the United Nations World Health Organization (WHO) said.
The deadly water-borne disease is a major public health concern from Tanzania to
The measles vaccine provides benefits beyond merely protecting against that highly contagious viral respiratory disease that remains a leading childhood killer in parts of the world, scientists said.
By blocking the measles infect
The world's first malaria vaccine, made by GlaxoSmithKline, could be approved by international regulators for use in Africa from October after final trial data showed it offered partial protection for up to four years.
An independent advisory body will decide in August at the earliest on whether to recommend widespread introduction of an Ebola vaccine, depending on results of clinical trials and the epidemic's course, the World Health Organization said.